Hudock, Inc. Zoetis Inc. Transaction History

Hudock, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$181.39 - $234.03 $2,902 - $3,744	-16 Reduced 13.68%	101 $19,000
Q4 2020 Feb 05, 2021	SELL	$157.07 - $174.35 $2,670 - $2,963	-17 Reduced 12.69%	117 $19,000
Q3 2020 Oct 23, 2020	SELL	$137.1 - $165.37 $13,710 - $16,537	-100 Reduced 42.74%	134 $22,000
Q2 2020 Aug 11, 2020	BUY	$111.92 - $142.53 $3,805 - $4,846	34 Added 17.0%	234 $32,000
Q1 2020 Apr 27, 2020	BUY	$92.66 - $144.94 $18,532 - $28,988	200 New	200 $23,000
Q4 2019 Jan 21, 2020	SELL	$116.25 - $133.25 $46,500 - $53,300	-400 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$112.57 - $128.43 $45,028 - $51,372	400 New	400 $49,000
Q2 2018 Aug 01, 2018	SELL	$79.9 - $89.2 $11,985 - $13,380	-150 Closed	0 $0
Q1 2018 Apr 27, 2018	BUY	$71.51 - $84.69 $10,726 - $12,703	150 New	150 $12,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

Stay updated on Hudock, Inc. with notifications on news.